APA

Heinze S., Egberts F., Rötzer S., Volkenandt M., Tilgen W., Linse R., Boettjer J., Vogt T., Spieth K., Eigentler T., Brockmeyer N. H., Hinzpeter A., Hauschild A. & Schaefer M. (20100302). Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial. : Journal of immunotherapy (Hagerstown, Md. : 1997).

Chicago

Heinze Sarah, Egberts Friederike, Rötzer Susanne, Volkenandt Matthias, Tilgen Wolfgang, Linse Ruthild, Boettjer Jörg, Vogt Thomas, Spieth Konstanze, Eigentler Thomas, Brockmeyer Norbert H, Hinzpeter Axel, Hauschild Axel and Schaefer Martin. 20100302. Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial. : Journal of immunotherapy (Hagerstown, Md. : 1997).

Harvard

Heinze S., Egberts F., Rötzer S., Volkenandt M., Tilgen W., Linse R., Boettjer J., Vogt T., Spieth K., Eigentler T., Brockmeyer N. H., Hinzpeter A., Hauschild A. and Schaefer M. (20100302). Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial. : Journal of immunotherapy (Hagerstown, Md. : 1997).

MLA

Heinze Sarah, Egberts Friederike, Rötzer Susanne, Volkenandt Matthias, Tilgen Wolfgang, Linse Ruthild, Boettjer Jörg, Vogt Thomas, Spieth Konstanze, Eigentler Thomas, Brockmeyer Norbert H, Hinzpeter Axel, Hauschild Axel and Schaefer Martin. Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial. : Journal of immunotherapy (Hagerstown, Md. : 1997). 20100302.